A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Thomas Jefferson University
Thomas Jefferson University
St. Jude Children's Research Hospital
Orca Biosystems, Inc.
Gamida Cell ltd
City of Hope Medical Center
Masonic Cancer Center, University of Minnesota
H. Lee Moffitt Cancer Center and Research Institute
City of Hope Medical Center
Baylor College of Medicine
City of Hope Medical Center
Stanford University
Center for International Blood and Marrow Transplant Research
Masonic Cancer Center, University of Minnesota
Roswell Park Cancer Institute
M.D. Anderson Cancer Center
City of Hope Medical Center
City of Hope Medical Center
Masonic Cancer Center, University of Minnesota
M.D. Anderson Cancer Center
Thomas Jefferson University
University of Michigan Rogel Cancer Center
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
Washington University School of Medicine
Fred Hutchinson Cancer Center
City of Hope Medical Center
Fred Hutchinson Cancer Center
Ensoma
Stanford University
City of Hope Medical Center
Kyowa Kirin Co., Ltd.
Fred Hutchinson Cancer Center
Novartis
Washington University School of Medicine
University of Nebraska
University of Nebraska
M.D. Anderson Cancer Center
Bellicum Pharmaceuticals
University of Nebraska
Bellicum Pharmaceuticals
National Institutes of Health Clinical Center (CC)
Center for International Blood and Marrow Transplant Research
Case Comprehensive Cancer Center
Stanford University
M.D. Anderson Cancer Center
Rutgers, The State University of New Jersey
Northside Hospital, Inc.
Fate Therapeutics
Oncoimmune, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Karyopharm Therapeutics Inc